Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
48.70
-0.82 (-1.66%)
May 28, 2026, 3:27 PM EDT - Market open

Spruce Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
54.0848.9138.7596.3424.4942.75
Short-Term Investments
----54.5946.22
Cash & Short-Term Investments
54.0848.9138.7596.3479.0888.97
Cash Growth
111.13%26.20%-59.77%21.83%-11.12%-43.39%
Other Current Assets
0.953.215.455.844.532.93
Total Current Assets
55.0352.1144.21102.1883.6191.9
Net Property, Plant & Equipment
0.60.670.931.181.41.48
Long-Term Investments
-----32.46
Other Long-Term Assets
0.540.240.070.580.640.65
Total Assets
56.1753.0245.21103.9585.65126.49
Accounts Payable
2.680.941.33.331.432.82
Accrued Expenses
8.19.1412.3314.69.46.05
Current Portion of Long-Term Debt
1-1.621.621.62-
Unearned Revenue
---4.91--
Total Current Liabilities
11.7810.0915.2524.4712.458.87
Long-Term Debt
5.46-0.121.723.294.88
Long-Term Leases
0.330.420.741.021.261.29
Other Long-Term Liabilities
3.94-0.280.240.160.07
Total Long-Term Liabilities
9.730.421.142.974.726.24
Total Liabilities
21.5210.5116.3927.4417.1615.12
Common Stock
---000
Additional Paid-in Capital
336.15331.75279.09273.74218.35214.69
Accumulated Other Comprehensive Income
-----0.56-0.18
Retained Earnings
---250.27-197.23-149.31-103.13
Shareholders' Equity
336.15331.7528.8276.5168.49111.37
Total Liabilities & Equity
56.1753.0245.21103.9585.65126.49
Total Debt
6.80.422.484.366.186.17
Net Cash (Debt)
47.2848.4936.2791.9872.982.8
Net Cash Growth
-2.48%33.68%-60.57%26.17%-11.95%-45.17%
Net Cash Per Share
49.4663.2565.93179.14232.40265.82
Book Value
336.15331.7528.8276.5168.49111.37
Book Value Per Share
351.61432.7652.39149.00218.32357.55
Tangible Book Value
336.15331.7528.8276.5168.49111.37
Tangible Book Value Per Share
351.61432.7652.39149.00218.32357.55
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.